Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Vigil Neuroscience, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −2 vs. Q2 2022
- Shares held
- 24.6M
- +7.21M (+41.6%) vs. Q2 2022
- Total value
- $222.7M
- +$178.1M (+399.5%) vs. Q2 2022
- New holders
- 6
- 12 more added
- Sold out
- 8
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $0 | 0.00% | −212−99.1% | Reduced |
| Wells Fargo & Company | 54 | $0 | 0.00% | +7+14.9% | Added |
| State of Wyoming | 46 | $0 | 0.00% | +46 | New |
| Morgan Stanley | 130 | $1.00K | 0.00% | −3,208−96.1% | Reduced |
| Royal Bank of Canada | 1,000 | $9.00K | 0.00% | +1,000 | New |
| Cannell Capital LLC | 8,044 | $73.0K | 0.02% | +4,408+121.2% | Added |
| Northern Trust Corp | 12,082 | $110.0K | 0.00% | 00.0% | Unchanged |
| Altium Capital Management LP | 15,788 | $144.0K | 0.05% | +15,788 | New |
| State Street Corp | 21,374 | $195.0K | 0.00% | +3,000+16.3% | Added |
| Adage Capital Partners GP, L.L.C. | 22,269 | $203.0K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 26,955 | $245.0K | 0.00% | +26,915+67,287.5% | Added |
| Ergoteles LLC | 28,533 | $260.0K | 0.01% | +28,533 | New |
| Citigroup Inc | 67,655 | $616.0K | 0.00% | +2,592+4.0% | Added |
| Geode Capital Management, LLC | 71,819 | $653.0K | 0.00% | +12,174+20.4% | Added |
| Goldman Sachs Group Inc | 73,024 | $665.0K | 0.00% | −53−0.1% | Reduced |
| BlackRock Inc. | 101,725 | $926.0K | 0.00% | −2,498−2.4% | Reduced |
| Barclays PLC | 102,163 | $929.0K | 0.00% | +482+0.5% | Added |
| Laurion Capital Management LP | 130,200 | $1.19M | 0.03% | 00.0% | Unchanged |
| Logos Global Management LP | 205,595 | $1.87M | 0.23% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 216,395 | $1.97M | 0.53% | +116,641+116.9% | Added |
| Harvard Management Co Inc | 289,460 | $2.63M | 0.33% | 00.0% | Unchanged |
| Vanguard Group Inc | 365,426 | $3.33M | 0.00% | +11,218+3.2% | Added |
| OrbiMed Advisors LLC | 411,191 | $3.74M | 0.07% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $4.29M | 0.11% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $5.10M | 1.86% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 616,786 | $5.61M | 0.39% | 00.0% | Unchanged |
| BVF Inc | 1,813,633 | $16.5M | 0.68% | +1,813,633 | New |
| Deerfield Management Company, L.P. (Series C) | 2,054,794 | $18.0M | 0.36% | +2,054,794 | New |
| Citadel Advisors LLC | 2,166,467 | $19.7M | 0.02% | +1,431+0.1% | Added |
| Artal Group S.A. | 2,285,574 | $20.8M | 1.09% | +1,164,383+103.9% | Added |
| Deep Track Capital, LP | 2,363,188 | $21.5M | 1.06% | +2,054,795+666.3% | Added |
| Northpond Ventures, LLC | 4,214,498 | $38.4M | 26.88% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $53.1M | 5.86% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −37,488−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −25,337−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −12,139−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,448−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,118−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −14,337−100.0% | Sold out |